Pancragen is one of the Khavinson short peptides. Nearly all published work is animal or cell research from a small number of Russian groups.

Pancragen

Animal studies only

Almost all the research is in animals. We do not know if the same thing happens in people.

A short peptide from Russian research, studied in animals for pancreas and blood sugar.

The basics

What is it?: Pancragen is one of the Khavinson short peptides. Nearly all published work is animal or cell research from a small number of Russian groups.

No. Pharmacies are not on record as being allowed to make this into a medicine.

The FDA has not approved this as a medicine.

Not FDA approved and not on the U.S. compounding list. A doctor cannot prescribe it.

Official status: Not on the 503A bulks list. Checked 2026-08-04.

Lab suppliers we list: 4

Taken word for word from the studies and trials listed on this page. This is not a recommendation and not a dose for anyone to take.

These are doses given to animals, usually per kilogram of body weight. They do not convert directly to a human dose.

0.05 ng
rats ·
[The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats].Advances in gerontology = Uspekhi gerontologii · 2006
“The peptide effective concentration of 0.05 ng/ml showed a stimulating effect in appropriate tissue cultures as compared to the control explants in all groups of rats.”
See source wording
monkeys · into a muscle · for 10 days
[Correction of impaired glucose tolerance using tetrapeptide (Pancragen) in old female rhesus monkeys].Advances in gerontology = Uspekhi gerontologii · 2015
“Five of them were injected with Pancragen (0,05 mg/animal per day during 10 days, intramuscularly) for 10 days; 4 animals received glimepiride (4 mg/animal per day during 10 days, per os).”
50 mcg
monkeys · into a muscle · for 10 days
[Impact of tetrapeptide pancragen on endocrine function of the pancreas in old monkeys].Advances in gerontology = Uspekhi gerontologii · 2014
“Pancragen administration (50 μg/animal per day during 10 days, intramuscularly) to old monkeys caused markedly increased the glucose "disappear- ance" rate, normalized the plasma insulin and C-peptide dynamics in response to glucose administration.”